Name: 글로벌 시장 동향
SKU: PH7783
Availability: InStock

보고서 요약(국문)

개요
글로벌 효능 시험 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
효능 시험은 제품의 포장 및 마케팅이 제품 설명에 명시된 의도된 용도를 정확하게 반영하는지 확인하는 시험입니다. 이 시험은 제품이 인체에 사용되었을 때 발생할 수 있는 이점이나 유해성을 조사합니다. 제품에 따라 다양한 효능 시험을 수행할 수 있으며, 특정 기준을 충족하는지 여부를 판단하기 위해 맞춤형 분석을 실시할 수 있습니다. 시험 결과가 성공적으로 나오면 관련 당국에 제품의 효능을 입증하는 증거로 활용될 수 있습니다.
시장 동향: 동인 및 제약 요인
제약 부문의 연구 개발 아웃소싱 증가
아웃소싱을 통해 제약 회사는 운영 및 생산 비용을 절감하고 재정적 위험을 줄일 수 있습니다. 그 결과, 제약 회사들은 연구 개발 전략의 일환으로 민간 임상시험수탁기관(CRO)에 연구 개발 업무를 아웃소싱하는 사례가 증가하고 있습니다.

예를 들어, 2022년 9월 임상 단계 생명공학 기업인 에미리아(Emyria Limited)는 신경과학 분야의 전임상 신약 개발 및 임상시험수탁기관(CRO)인 사이코제닉스(PsychoGenics)와 협력했습니다. 이 협력을 통해 에미리아는 사이코제닉스의 차세대 자동화 테스트 플랫폼인 스마트큐브(SmartCube)를 활용합니다. 이러한 사례들은 효능 테스트 제품에 대한 수요 증가를 촉진할 것으로 예상되며, 이는 예측 기간 동안 시장 성장에 기여할 것으로 전망됩니다.
또한, 전 세계 효능 테스트 시장은 소비자의 건강에 대한 관심 증가, 화장품 수요 증가 등 다양한 요인에 의해 성장하고 있습니다.

시장 동향: 제약 요인
효능 테스트 시장은 여러 가지 요인에 의해 제약을 받고 있는데, 그중 하나는 화학 소독제의 부작용입니다. 현재 시판되는 대부분의 화학 소독제는 독성을 가지고 있습니다. 또한, 테스트 절차에 소요되는 시간과 자본의 높은 투자, 규제 장벽 등도 예측 기간 동안 시장 성장을 저해할 것으로 예상됩니다.

시장 세분화 분석
글로벌 효능 시험 시장은 서비스 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
서비스 유형 부문 중 소독제 효능 시험 부문은 전체 효능 시험 시장 점유율의 약 54.2%를 차지했습니다.
소독제 효능 시험 부문은 약 54.2%의 시장 점유율을 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 소독제 효능 시험은 사용되는 환경에서 소독제가 대상으로 하는 미생물에 대해 살균 효과를 측정하는 것입니다.
예를 들어, 의료기기 개발의 모든 단계에 걸쳐 종합 서비스를 제공하는 미국 기업인 STEMart는 2023년 10월 의료기기의 안전성을 보장하기 위해 다양한 표준에 따른 소독 효능 연구 서비스를 출시했다고 발표했습니다. 이 서비스는 박테리아, 효모, 바이러스, 곰팡이를 포함한 광범위한 미생물에 대한 소독제의 효과를 평가하는 데 사용할 수 있습니다.

지리적 분석
북미는 2022년 시장 점유율의 약 39.4%를 차지했습니다.
북미는 임상 시험 증가, 연구 개발 투자 확대, 품질 설계(QbD) 방식 도입 등 시장 성장을 견인할 것으로 예상되는 요인들로 인해 예측 기간 동안 전체 시장 점유율의 약 39.4%를 유지할 것으로 전망됩니다.
예를 들어, 2022년 5월, 화이자-바이오엔텍 코로나19 백신은 3차 접종 후 6개월~5세 미만 어린이에게서 강력한 면역 반응, 높은 효능, 양호한 안전성을 입증했습니다. 오미크론(Omicron) 변이형을 사용한 3회 접종에 대한 기술 분석 결과, 백신 효능은 80.3%로 나타났습니다.

또한, 2020년 11월, 화이자(Pfizer Inc.)와 바이오엔텍(BioNTech SE)은 SARS-CoV-2 감염 이력이 없는 참가자를 대상으로 한 mRNA 기반 백신 후보 물질인 BNT162b2가 COVID-19에 대한 효능을 보였다고 발표했습니다. 이는 2020년 11월 8일 외부 독립 데이터 모니터링 위원회(DMC)가 실시한 3상 임상 연구의 첫 번째 중간 효능 분석 결과에 따른 것입니다.
COVID-19 영향 분석
COVID-19 팬데믹은 사람들의 청결에 대한 인식을 변화시켜 소독 제품에 대한 긴급 수요를 발생시켰고, 이로 인해 공급이 빠르게 소진되면서 관련 산업의 성장을 가속화했습니다. 더 나아가, 미국 환경보호청(EPA)이 COVID-19 퇴치를 위한 "승인" 목록에 여러 천연 소독제를 추가함에 따라, 각국 정부는 예방 및 치료제 개발, 중환자 치료 의료기기 구매, 진단 검사 신속 승인을 위한 특별 재정 지원을 발표했습니다.

시장 세분화
서비스 유형별
• 소독제 효능 시험
o 표면 시험법
o 현탁액 시험법
• 항균 효능 시험
o 기존 시험법
o 신속 시험법
응용 분야별
• 제약 제조
• 화장품 및 개인 위생용품
• 소비재
• 의료기기
• 기타
최종 사용자별
• 제약 및 생명공학 기업
• 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Abbott Analytical, Accugen Laboratories, Inc., Almac Group, ALS Limited, Bioscience Laboratories, Inc. 등이 있습니다. 블루테스트 래버러토리스 리미티드, 찰스 리버 래버러토리스 인터내셔널, Inc., 컨슈머 프로덕트 테스팅 컴퍼니(CPTC), 유로핀스 사이언티픽, 루시데온 등이 있습니다.
주요 개발 사항
 2022년 6월, 유로핀스 코스메틱 & 퍼스널 케어는 한국에 본사를 둔 임상 시험 기관인 CRA 코리아의 지분 과반수를 인수했습니다. CRA 코리아는 주로 화장품 및 퍼스널 케어 산업에 안전성 및 효능 연구, 소비자 테스트, 관능 평가 서비스를 제공합니다.

 2022년 4월, MSL 솔루션 프로바이더스는 UV 기기 효능 시험법을 도입했습니다. 이 새로운 방법은 시험 표면에서 UV 방출기까지의 거리를 표준화하여 전력 대 접촉 시간 평가를 가능하게 합니다. 기존 EN 17272:2020 표준을 기반으로 살균, 항결핵균, 항포자, 항효모, 항진균, 항바이러스 및 항식균 작용을 측정하는 UV 기기 효능 시험을 포함합니다.

 2020년 5월, 글로벌 헬스케어 및 감염 예방 제품 및 솔루션 선도 기업인 다이버시(Diversey, Inc.)는 코로나19를 유발하는 SARS-CoV-2 바이러스에 대한 자사 소독제 제품의 효능 테스트를 진행할 것이라고 발표했습니다. 이 결과는 미국 환경보호청(EPA)의 승인을 위해 제출될 예정입니다.
보고서 구매 이유:

• 서비스 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 효능 테스트 시장 세분화 현황을 시각화하고 주요 기업 및 주요 업체를 파악할 수 있습니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴할 수 있습니다.

• 모든 세그먼트를 포함한 효능 테스트 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품 정보를 담은 엑셀 파일 형태의 제품 맵핑 자료를 제공합니다.

글로벌 효능 테스트 시장 보고서는 약 77개의 표, 79개의 그림, 187페이지 분량으로 구성되어 있습니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Efficacy Testing Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
An efficacy test ensures that the packaging and marketing of a product accurately reflect the intended use of any statement of the product. It investigates the benefits or harms a product may cause when used on or by humans. Various efficacy tests can be performed, depending on the product, and assays can be tailor-made to determine whether the product meets particular criteria. The results of a successful test can be used to give evidence of the efficacy of a product to the relevant authority.
Market Dynamics: Drivers and Restraints
Rise in outsourcing of research and development by the pharmaceutical sector
Outsourcing enables pharmaceutical companies to cut both their operating and production expenses, reducing financial risk. As a result, pharmaceutical corporations are increasingly outsourcing R&D operations to private contract research organisations (CROs) as a research and development strategy.
For instance, in September 2022, Emyria Limited, a clinical-stage biotechnology company collaborated with PsychoGenics, a neuroscience preclinical drug discovery and contract research organization (CRO). Under this collaboration, Emyria uses PsychoGenic's drug discovery platform, SmartCube, which is a next-generation automated testing platform. Such instances are expected to increase the demand for efficacy testing products, and hence, it is anticipated to contribute to market growth over the forecast period.
Furthermore, the global efficacy testing market is also driven by various other factors like, rise in consumer health concerns, an increase in cosmetic products and others which help the market to grow during the forecast period.
Market Dynamics: Restraint
The efficacy testing market is hampered by various factors some of which are adverse effects of chemical disinfectants, Most of the chemical disinfectants currently available in the market have toxic properties. Also, other factors like high investment of time and capital in the testing procedures, regulatory hurdles and others will also hamper the market growth during the forecast period.
Segment Analysis
The global efficacy testing market is segmented based on service type, application, end-user and region.
The disinfectant efficacy testing segment from the service type segment accounted for approximately 54.2% of the efficacy testing market share
The disinfectant efficacy testing segment from the service type segment accounted for approximately 54.2% and is expected to be dominated during the forecast period. Disinfectant efficacy testing is the determination of the biocidal effect of a disinfectant in the environment which is used, against the organisms it is intended for use against.
For instance, in October 2023, STEMart, a US-based provider of comprehensive services for all phases of medical device development, stated the launch of its Disinfection Efficacy Studies Services in various standards to ensure the safety of medical devices. The services can be performed to evaluate the effectiveness of disinfectants against a wide range of microorganisms, including bacteria, yeast, viruses, and fungi.
Geographical Analysis
North America accounted for approximately 39.4% of the market share in 2022
North America is estimated to hold about 39.4% of the total market share throughout the forecast period, owing to the factors like, a rise in clinical trials, increasing R&D and adoption of the quality by design (QbD) approach among the market players in the region, which are predicted to drive market growth.
For instance, in May 2022, the Pfizer-BioNTech COVID-19 vaccine demonstrated a strong immune response, high efficacy, and favourable safety in children 6 months to under 5 years following the third dose. Vaccine efficacy of 80.3% was observed in the descriptive analysis of three doses when Omicron was the predominant variant.
Moreover, in November 2020, Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2, has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020, by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.
COVID-19 Impact Analysis
The COVID-19 pandemic altered people's perceptions of cleanliness, resulting in an urgent demand for disinfection goods that soon emptied their supply, accelerating the industry's expansion. Furthermore, in response to the EPA adding numerous natural disinfectants to its "approved" list for combating COVID-19, governmental organisations announced special financial aid for the development of preventive and curative drugs, the purchase of critical care medical devices, and the expedited approval of diagnostic tests.
Market Segmentation
By Service Type
• Disinfectant Efficacy Testing
o Surface Test Method
o Suspension Test Method
• Antimicrobial Efficacy Testing
o Traditional Test Method
o Rapid Test Method
By Application
• Pharmaceutical Manufacturing
• Cosmetics and Personal Care Products
• Consumer Product
• Medical Devices
• Others
By End User
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Abbott Analytical, Accugen Laboratories, Inc., Almac Group, ALS Limited, Bioscience Laboratories, Inc., Blutest Laboratories Limited, Charles River Laboratories International, Inc., Consumer Product Testing Company (CPTC), Eurofins Scientific, Lucideon among others.
Key Developments
 In June 2022, Eurofins Cosmetics & Personal Care acquired a majority stake in CRA Korea Inc., a South Korea-based clinical testing laboratory primarily focused on providing safety and efficacy studies, consumer tests, and sensory evaluation to the cosmetics and personal care industry.
 In April 2022, MSL Solution Providers introduced efficacy testing of UV devices. The new method standardises the distance of UV emitters from test surfaces, allowing for power versus contact time assessment. It covers UV device efficacy testing, determining bactericidal, mycobactericidal, sporicidal, yeasticidal, fungicidal, virucidal, and phagocidal activities, based on existing EN 17272:2020 standards.
 In May 2020, Diversey, Inc., a global leader in healthcare and infection prevention products and solutions, stated it would test several of its disinfectant products for efficacy against SARS-CoV-2, which causes COVID-19. These results will be submitted to the EPA for approval.
Why Purchase the Report?
• To visualize the global efficacy testing market segmentation based on service type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of efficacy testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global efficacy testing market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Service Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in outsourcing of research and development by the pharmaceutical sector
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High investment of time and capital in the testing procedures
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Service Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
7.1.2. Market Attractiveness Index, By Service Type
7.2. Disinfectant Efficacy Testing *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Antimicrobial Efficacy Testing
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Pharmaceutical Manufacturing *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cosmetics and Personal Care Products
8.4. Consumer Product
8.5. Medical Devices
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Pharmaceutical & Biotechnology Companies *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
10.5.5.4. Australia
10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Abbott Analytical *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Accugen Laboratories, Inc
12.3. Almac Group
12.4. ALS Limited
12.5. Bioscience Laboratories, Inc.
12.6. Blutest Laboratories Limited
12.7. Charles River Laboratories International, Inc
12.8. Consumer Product Testing Company (CPTC)
12.9. Eurofins Scientific
12.10. Lucideon
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Abbott Analytical, 4.	Key Developments, Accugen Laboratories, Inc, Almac Group, ALS Limited, Bioscience Laboratories, Inc., Blutest Laboratories Limited, Charles River Laboratories International, Inc, Consumer Product Testing Company (CPTC), Eurofins Scientific, Lucideon

표 목록 (Tables)

List of Tables

Table 1 Global Efficacy Testing Market Value, By Service Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Efficacy Testing Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Efficacy Testing Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Efficacy Testing Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Efficacy Testing Market Value, By Service Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Efficacy Testing Market Value, By Service Type, 2022-2031 (US$ Million)

Table 7 Global Efficacy Testing Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Efficacy Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Efficacy Testing Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Efficacy Testing Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Efficacy Testing Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Efficacy Testing Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Efficacy Testing Market Value, By Service Type, 2022-2031 (US$ Million)

Table 14 North America Efficacy Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Efficacy Testing Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Efficacy Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Efficacy Testing Market Value, By Service Type, 2022-2031 (US$ Million)

Table 18 South America Efficacy Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Efficacy Testing Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Efficacy Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Efficacy Testing Market Value, By Service Type, 2022-2031 (US$ Million)

Table 22 Europe Efficacy Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Efficacy Testing Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Efficacy Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Efficacy Testing Market Value, By Service Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Efficacy Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Efficacy Testing Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Efficacy Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Efficacy Testing Market Value, By Service Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Efficacy Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Efficacy Testing Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Abbott Analytical: Overview

Table 33 Abbott Analytical: Product Portfolio

Table 34 Abbott Analytical: Key Developments

Table 35 Accugen Laboratories, Inc: Overview

Table 36 Accugen Laboratories, Inc: Product Portfolio

Table 37 Accugen Laboratories, Inc: Key Developments

Table 38 Almac Group: Overview

Table 39 Almac Group: Product Portfolio

Table 40 Almac Group: Key Developments

Table 41 ALS Limited: Overview

Table 42 ALS Limited: Product Portfolio

Table 43 ALS Limited: Key Developments

Table 44 Bioscience Laboratories, Inc.: Overview

Table 45 Bioscience Laboratories, Inc.: Product Portfolio

Table 46 Bioscience Laboratories, Inc.: Key Developments

Table 47 Blutest Laboratories Limited: Overview

Table 48 Blutest Laboratories Limited: Product Portfolio

Table 49 Blutest Laboratories Limited: Key Developments

Table 50 Charles River Laboratories International, Inc: Overview

Table 51 Charles River Laboratories International, Inc: Product Portfolio

Table 52 Charles River Laboratories International, Inc: Key Developments

Table 53 Consumer Product Testing Company (CPTC): Overview

Table 54 Consumer Product Testing Company (CPTC): Product Portfolio

Table 55 Consumer Product Testing Company (CPTC): Key Developments

Table 56 Eurofins Scientific: Overview

Table 57 Eurofins Scientific: Product Portfolio

Table 58 Eurofins Scientific: Key Developments

Table 59 Lucideon: Overview

Table 60 Lucideon: Product Portfolio

Table 61 Lucideon: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 2 Global Efficacy Testing Market Share, By Service Type, 2022 & 2030 (%)

Figure 3 Global Efficacy Testing Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Efficacy Testing Market Share, By End User, 2022 & 2030 (%)

Figure 5 Global Efficacy Testing Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Efficacy Testing Market Y-o-Y Growth, By Service Type, 2022-2030 (%)

Figure 7 Disinfectant Efficacy Testing Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 8 Antimicrobial Efficacy Testing Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 9 Global Efficacy Testing Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 10 Pharmaceutical Manufacturing Application in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 11 Cosmetics and Personal Care Product Application in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 12 Consumer Product Application in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 13 Medical Devices Application in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 14 Others Application in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 15 Global Efficacy Testing Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 16 Pharmaceutical & Biotechnology Companies End User in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 17 Research Institutes End User in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 18 Others End User in Global Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 19 Global Efficacy Testing Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 20 North America Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 21 Asia-Pacific Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 22 Europe Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 23 South America Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 24 Middle East and Africa Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 25 North America Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 26 North America Efficacy Testing Market Share, By Service Type, 2022 & 2030 (%)

Figure 27 North America Efficacy Testing Market Share, By Application, 2022 & 2030 (%)

Figure 28 North America Efficacy Testing Market Share, By End User, 2022 & 2030 (%)

Figure 29 North America Efficacy Testing Market Share, By Country, 2022 & 2030 (%)

Figure 30 South America Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 31 South America Efficacy Testing Market Share, By Service Type, 2022 & 2030 (%)

Figure 32 South America Efficacy Testing Market Share, By Application, 2022 & 2030 (%)

Figure 33 South America Efficacy Testing Market Share, By End User, 2022 & 2030 (%)

Figure 34 South America Efficacy Testing Market Share, By Country, 2022 & 2030 (%)

Figure 35 Europe Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 36 Europe Efficacy Testing Market Share, By Service Type, 2022 & 2030 (%)

Figure 37 Europe Efficacy Testing Market Share, By Application, 2022 & 2030 (%)

Figure 38 Europe Efficacy Testing Market Share, By End User, 2022 & 2030 (%)

Figure 39 Europe Efficacy Testing Market Share, By Country, 2022 & 2030 (%)

Figure 40 Asia-Pacific Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 41 Asia-Pacific Efficacy Testing Market Share, By Service Type, 2022 & 2030 (%)

Figure 42 Asia-Pacific Efficacy Testing Market Share, By Application, 2022 & 2030 (%)

Figure 43 Asia-Pacific Efficacy Testing Market Share, By End User, 2022 & 2030 (%)

Figure 44 Asia-Pacific Efficacy Testing Market Share, By Country, 2022 & 2030 (%)

Figure 45 Middle East & Africa Efficacy Testing Market Value, 2022-2031 (US$ Million)

Figure 46 Middle East & Africa Efficacy Testing Market Share, By Service Type, 2022 & 2030 (%)

Figure 47 Middle East & Africa Efficacy Testing Market Share, By Application, 2022 & 2030 (%)

Figure 48 Middle East & Africa Efficacy Testing Market Share, By End User, 2022 & 2030 (%)

Figure 49 Abbott Analytical: Financials

Figure 50 Accugen Laboratories, Inc: Financials

Figure 51 Almac Group: Financials

Figure 52 ALS Limited: Financials

Figure 53 Bioscience Laboratories, Inc.: Financials

Figure 54 Blutest Laboratories Limited: Financials

Figure 55 Charles River Laboratories International, Inc: Financials

Figure 56 Consumer Product Testing Company (CPTC): Financials

Figure 57 Eurofins Scientific: Financials

Figure 58 Lucideon: Financials

글로벌 효능 테스트 시장 – 2023-2030

Global Efficacy Testing Market - 2023-2030